Physician Holding Patient's PrescriptionsAs downward pressure on their incomes continues, physicians are seeking creative ways to supplement revenue while adding additional value to their patients.  A great option for large and small medical practices is pharmaceutical dispensing.  Offering medications at the point of care generates revenue (while offering competitive medication prices), increases compliance (because they walk out of the office with their meds) and provides great convenience (because they don’t have the extra stop and wait for their prescription).  Sounds like an easy decision, right?

The reality is that most physicians have little to no time available to evaluate point of care dispensing programs, the dispensing software supporting them or the vendor supplying them.   Brokers who are already working with physicians or practice groups are in a unique position to help the practitioner evaluate options and be a part of the solution.

In a recent discussion with a broker who provided benefits solutions to medical groups, we spent a lot of time discussing Northwind Pharmaceuticals.  He was vetting us.  The value of physician dispensing was evident, he wanted to make sure we were a reputable vendor who would support him as a trusted adviser to his clients.  This process is called “building a relationship” and it takes time.  You don’t build trust through one phone call.  Trust is built one interaction at a time over time.  It is very difficult for physicians to invest in this vetting process and it is a true value-add opportunity for brokers and consultants who already have the trusted relationship.

Test it.  The next time you are meeting with one of your physicians, ask them about it.  Then give us a call (800.722.0772) and we can walk you through how best to help your client benefit from adding medication dispensing to their service set.

Schedule a free claims analysis now.

Let’s Talk now

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading

Stewardship and the Beauty of Health Benefits

Phillip Berry | Oct 25th, 2024
The Beauty of Making a Difference Beauty in health benefits? What does that even mean? Think back on your experience as an HR/benefits professional. What are the peak moments? Most would agree that the high points are moments when they see their work directly impacting an employee or plan member. A time when the health … more »

continue reading